Cytokinetics extends GSK collaboration

Cytokinetics has added another year to its research collaboration pact with GlaxoSmithKline. That's the third extension for the biotech, which signed up with Glaxo back in 2001. Their partnership has delivered one early-stage cancer drug candidate now in early stage trials. Release

Suggested Articles

Almirall and Iktos will use the latter's AI technology to design new compounds that tick multiple drug criteria boxes.

Pfizer’s 2017 spinout company SpringWorks has lost president and founder Lara Sullivan, M.D., who has moved over to Pyxis Oncology as its new chief.

In this week's EuroBiotech Report, Sanofi inks $2.5B Synthorx takeover and posts sutimlimab data, Roche shares bispecific results and more.